Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Anlon Healthcare Ltd. Share Price
Day's Range
Day's Range
Low
₹13.02
High
₹13.57
Price Summary
| Previous Close | ₹13.11 |
|---|---|
| Day's Range | ₹13.02 - ₹13.57 |
| Open | ₹13.50 |
| 52 Week Range | ₹09.08 - ₹17.27 |
| Volume | 15,91,492 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 210.43 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 33.91 |
| TTM EPS (₹) | 0.39 |
| P/E Ratio | 0.00 |
| Book Value(₹) | 2.55 |
| PAT Margin (%) | 17.06 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 24.83 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | N/A | 93.61 |
| Expenses | N/A | N/A |
| PBT | N/A | -2.91 |
| Operating profit | N/A | 0.0 |
| Net profit | N/A | -24.86 |
About Anlon Healthcare Ltd.
| Founded | 2013 |
|---|---|
| Managing Director | Punitkumar R Rasadia |
| NSE Symbol | AHCL |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,37,662.69 | 1,824.10 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,75,692.42 | 6,618.20 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,43,908.69 | 4,252.05 | 3,101.60 - 3,101.60 |
| Apollo Hospitals Enterprise Ltd. | 1,11,261.29 | 7,727.50 | 6,677.50 - 6,677.50 |
| Cipla Ltd. | 1,07,826.86 | 1,334.85 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,07,499.64 | 1,287.95 | 1,129.40 - 1,129.40 |
| Lupin Ltd. | 1,07,489.16 | 2,350.00 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 98,438.74 | 1,011.45 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 93,323.97 | 2,266.80 | 1,909.70 - 1,909.70 |
| Zydus Lifesciences Ltd. | 90,727.09 | 901.65 | 835.50 - 835.50 |
No Records Found
Latest News
Anlon Healthcare informs about allotment of bonus equity shares
In continuation to its earlier intimation dated 6th March, 2026, 8th April, 2026 and 9th April, 2026, Anlon Healthcare has informed that the Board of Directors of the Company in its meeting held today, 27th April 2026 (the deemed allotment date), allotted 26,57,57,500 equity shares of Rs 2 each as fully paid-up bonus equity shares, in the proportion of 1:1, to the eligible members of the Company whose names appeared in the Register of Members / Register of the Beneficial Owners, as on 24th April 2026, the ‘Record Date’ fixed for this purpose. Consequent to the aforesaid allotment, the paid-up equity share capital of the Company stands increased to Rs. 1,06,30,30,000 divided into 53,15,15,000 equity shares of Rs. 2 each. The meeting commenced at 09:00 am and concluded at 9:15 am.
The above information is a part of company’s filings submitted to BSE.
Anlon Healthcare informs about share purchase agreement
Anlon Healthcare submits analyst meet intimation
Anlon Healthcare informs about disclosure
Anlon Healthcare informs about press release
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Anlon Healthcare Ltd. is ₹13.11 as of 2026-05-04.
The market capitalisation of Anlon Healthcare Ltd. is ₹695.75 as of 2026-05-04.
The 1-year return of Anlon Healthcare Ltd. is 0.00% as of 2026-05-04.
The P/E ratio of Anlon Healthcare Ltd. is 0.00 as of 2026-05-05.
The 52-week high and low of Anlon Healthcare Ltd. are ₹17.27 and ₹9.08, respectively, as of 2026-05-04.
Disclaimer
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
